End-to-End Expertise You Can Count On
Join Viant CEO Alton Shader as he takes you on a tour of Viant's end-to-end expertise and 'in it for life' culture.
Read white papers, technical tips, how-tos, and success stories of how we've partnered with customers to achieve their goals.
Join Viant CEO Alton Shader as he takes you on a tour of Viant's end-to-end expertise and 'in it for life' culture.
Virtual tour of capabilities to manufacture motion preservation spinal disc implants.
Viant produces over 100,000 feet of nitinol tubing annually.
From manufacturing transfers to new product introductions, Viant can help accelerate your time to market.
With over 10 years of experience and more than 170,000 spinal disc implants made, trust Viant’s Orthopedic Implant and Coatings Center of Excellence for your motion preservation spinal implant program.
$8 million investment, including new building & FDA-approved vacuum plasma spray (VPS) equipment, enhances in-house coating and single-source orthopedic implant capabilities
The tube is the foundation of many medical devices. Is your tubing supplier taking a holistic approach that will help you avoid costly missteps?
A novel technique for mechanically joining nitinol to other metal tubing could reduce cost and mitigate risk.
Viant offers a broad range of metal processing capabilities, including specialized processes such as complex machining and precision tube drawing and fabrication.
Viant offers a wide range of thermoplastic and elastomer molding capabilities, including specialized processes such as blow molding and thermoforming.
While new materials are being made available, orthopedic device makers still lean on the well-established options for most new development.
A large, market-leading orthopedics company turned to Viant for help in developing instruments for a high-profile, integrated joint replacement system.
Viant shares expertise on material advances in orthopedics including titanium-coated PEEK, Nitinol, and bioabsorbables.
A large surgical technology company was facing a competitive threat and needed to rapidly re-engineer one of its market-leading devices to lower the cost of use.
A large surgical device company was planning to commercialize a first-of-its-kind articulating vessel sealer to strengthen its portfolio in the advanced energy device segment of the laparoscopic surgery market.
A global surgical technology company needed an external partner to help develop and manufacture tubing for an advanced energy device with measurably better performance than other leading devices.